North America Liquid Biopsy Market to 2032
Overview
The North America Liquid Biopsy Market is expected to reach a 5,148.12 USD Billion by 2032 and is projected to grow at a CAGR of 22.26% from 2025 to 2032.
Revenue, 2024 (USD Billion)
1,493.98
Forecast, 2032 (USD Billion)
5,148.12
CAGR, 2024 - 2032
22.26%
Report Coverage
North America
North America Liquid Biopsy Market 2018-2032 USD Billion
North America Liquid Biopsy Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 1,493.98 USD Billion
- Projected Market Size (2032): 5,148.12 USD Billion
- CAGR (2025-2032): 22.26%
Key Findings of North America Liquid Biopsy Market
- The North America Liquid Biopsy Market was valued at 1,493.98 USD Billion in 2024.
- The North America Liquid Biopsy Market is likely to grow at a CAGR of 22.26% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Multi-Gene-Parallel Analysis in Technology Segment accounted for the largest share of the market with a revenue of 1,149.82 USD Billion
- The fastest growing segment Routine Screening in Clinical Application Segment grew Fastest with a CAGR of 27.03% during the forecast period from 2024 to 2032.
North America Liquid Biopsy Market Scope
North America Liquid Biopsy Market Segmentation & Scope
Product
- Services & Software
- Instruments
- Consumables & Accessories
Distribution Channel
- Others
- Third Party Distributor
- Direct Tender
End User
- Others
- Research Centres and Academic Institutes
- Diagnostics Centers
- Reference Laboratories
- Hospitals
Technology
- Single Gene Analysis
- Multi-Gene-Parallel Analysis
Clinical Application
- Others
- Patient Work-Up
- Recurrence Monitoring
- Treatment Monitoring
- Therapy Selection
- Routine Screening
Analytical
- Histology/Imaging
- Proteomic
- Molecular
Sample
- Others
- Saliva & Other Tissue Fluids Sample-Based
- Urine Sample-Based
- Blood Sample-Based
Biomaker
- Others
- Extracellular Vesicles
- Exosomes
- Cell-Free RNA
- Circulating Cell-Free DNA (CFDNA)
- Circulating Tumor Cells (CTCS)
Application
- Non-Cancer Applications
- Cancer Applications
North America Liquid Biopsy Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 1,493.98 USD Billion |
| Market Value in 2032 | 5,148.12 USD Billion |
| CAGR (2025-2032) | 22.26% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Product,Distribution Channel,End User,Technology,Clinical Application,Analytical,Sample,Biomaker,Application |
Regional Insights:
-
Leading Market (2024-2032): North America, leading in terms of revenue 1,493.98 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 1,187.87 USD Billion in 2024.
Segments and Scope
-
North America Liquid Biopsy Market to 2032, By Product
- Consumables & Accessories is the largest segment in North America Liquid Biopsy Market to 2032 with a revenue of 758.01 USD Billion in the year 2024.
- Consumables & Accessories is the Fastest growing segment in North America Liquid Biopsy Market to 2032 with a Growth rate of 23.51 % in forecast period 2025-2032.
-
North America Liquid Biopsy Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in North America Liquid Biopsy Market to 2032 with a revenue of 970.19 USD Billion in the year 2024.
- Direct Tender is the Fastest growing segment in North America Liquid Biopsy Market to 2032 with a Growth rate of 23.17 % in forecast period 2025-2032.
-
North America Liquid Biopsy Market to 2032, By End User
- Hospitals is the largest segment in North America Liquid Biopsy Market to 2032 with a revenue of 820.23 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in North America Liquid Biopsy Market to 2032 with a Growth rate of 23.48 % in forecast period 2025-2032.
-
North America Liquid Biopsy Market to 2032, By Technology
- Multi-Gene-Parallel Analysis is the largest segment in North America Liquid Biopsy Market to 2032 with a revenue of 1,149.82 USD Billion in the year 2024.
- Multi-Gene-Parallel Analysis is the Fastest growing segment in North America Liquid Biopsy Market to 2032 with a Growth rate of 23.02 % in forecast period 2025-2032.
-
North America Liquid Biopsy Market to 2032, By Clinical Application
- Routine Screening is the largest segment in North America Liquid Biopsy Market to 2032 with a revenue of 579.50 USD Billion in the year 2024.
- Routine Screening is the Fastest growing segment in North America Liquid Biopsy Market to 2032 with a Growth rate of 27.03 % in forecast period 2025-2032.
-
North America Liquid Biopsy Market to 2032, By Analytical
- Molecular is the largest segment in North America Liquid Biopsy Market to 2032 with a revenue of 818.41 USD Billion in the year 2024.
- Proteomic is the Fastest growing segment in North America Liquid Biopsy Market to 2032 with a Growth rate of 23.33 % in forecast period 2025-2032.
-
North America Liquid Biopsy Market to 2032, By Sample
- Blood Sample-Based is the largest segment in North America Liquid Biopsy Market to 2032 with a revenue of 788.86 USD Billion in the year 2024.
- Blood Sample-Based is the Fastest growing segment in North America Liquid Biopsy Market to 2032 with a Growth rate of 24.02 % in forecast period 2025-2032.
-
North America Liquid Biopsy Market to 2032, By Biomaker
- Circulating Tumor Cells (CTCS) is the largest segment in North America Liquid Biopsy Market to 2032 with a revenue of 535.18 USD Billion in the year 2024.
- Circulating Tumor Cells (CTCS) is the Fastest growing segment in North America Liquid Biopsy Market to 2032 with a Growth rate of 26.16 % in forecast period 2025-2032.
-
North America Liquid Biopsy Market to 2032, By Application
- Cancer Applications is the largest segment in North America Liquid Biopsy Market to 2032 with a revenue of 1,143.50 USD Billion in the year 2024.
- Cancer Applications is the Fastest growing segment in North America Liquid Biopsy Market to 2032 with a Growth rate of 22.94 % in forecast period 2025-2032.
North America Liquid Biopsy Market Company Share Analysis
| Company Name |
|
||
| Thermo Fisher Scientific Inc. | |||
| QIAGEN | |||
| Guardant Health | |||
| Exact Sciences Corporation | |||
| F. Hoffmann-La Roche Ltd. | |||
North America Liquid Biopsy Market Geographical Sales Distribution, 2018-2032 USD Billion
North America Liquid Biopsy Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The North America Liquid Biopsy Market is segmented based on Segmentation Product,Distribution Channel,End User,Technology,Clinical Application,Analytical,Sample,Biomaker,Application.
North America Liquid Biopsy Market was valued at USD 1,493.98(Revenue in USD Billion) in 2021.
North America Liquid Biopsy Market is projected to grow at a CAGR of 22.26% during the forecast period of 2024 to 2032.
The Multi-Gene-Parallel Analysis segment is expected to dominate the North America Liquid Biopsy Market, holding a largest market share of 1,149.82 USD Billion in 2024
North America Liquid Biopsy Market Scope
North America Liquid Biopsy Market Segmentation & Scope
Product
- Services & Software
- Instruments
- Consumables & Accessories
Distribution Channel
- Others
- Third Party Distributor
- Direct Tender
End User
- Others
- Research Centres and Academic Institutes
- Diagnostics Centers
- Reference Laboratories
- Hospitals
Technology
- Single Gene Analysis
- Multi-Gene-Parallel Analysis
Clinical Application
- Others
- Patient Work-Up
- Recurrence Monitoring
- Treatment Monitoring
- Therapy Selection
- Routine Screening
Analytical
- Histology/Imaging
- Proteomic
- Molecular
Sample
- Others
- Saliva & Other Tissue Fluids Sample-Based
- Urine Sample-Based
- Blood Sample-Based
Biomaker
- Others
- Extracellular Vesicles
- Exosomes
- Cell-Free RNA
- Circulating Cell-Free DNA (CFDNA)
- Circulating Tumor Cells (CTCS)
Application
- Non-Cancer Applications
- Cancer Applications
Frequently Asked Questions
The North America Liquid Biopsy Market is segmented based on Segmentation Product,Distribution Channel,End User,Technology,Clinical Application,Analytical,Sample,Biomaker,Application.
North America Liquid Biopsy Market was valued at USD 1,493.98(Revenue in USD Billion) in 2021.
North America Liquid Biopsy Market is projected to grow at a CAGR of 22.26% during the forecast period of 2024 to 2032.
The estimated market value of the North America Liquid Biopsy Market for final year is USD 5,148.12 (USD Billion).
North America Liquid Biopsy Market Company Profiling
Frequently Asked Questions
The North America Liquid Biopsy Market is segmented based on Segmentation Product,Distribution Channel,End User,Technology,Clinical Application,Analytical,Sample,Biomaker,Application.
North America Liquid Biopsy Market was valued at USD 1,493.98(Revenue in USD Billion) in 2021.
North America Liquid Biopsy Market is projected to grow at a CAGR of 22.26% during the forecast period of 2024 to 2032.
The estimated market value of the North America Liquid Biopsy Market for final year is USD 5,148.12 (USD Billion).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.